spawns Hutchmed (NASDAQ:HCM) ADRs traded higher on Friday after regulators in China agreed to review the company’s lymphoma therapy tazemetostat, developed and sold in partnership with Ipsen (OTCPK:IPSEY). China’s National Medical Products Administration (NMPA) granted priority review for the new drug application (NDA) targeting adults with relapsed or refractory (“R/R”)Continue Reading
Sean Gallup/Getty Images News Germany’s government said Wednesday it has blocked the planned sale of the gas turbine business of Volkswagen’s (OTCPK:VWAGY) (OTCPK:VLKAF) MAN Energy Solutions unit to a Chinese company, citing security reasons. The sale to Chinese state-owned CSIC Longjiang GH Gas Turbine Co., a subsidiary of China StateContinue Reading
WANAN YOSSINGKUM/iStock via Getty Images China is leading other countries in generative AI inventions such as chatbots as it submitted six times more patents than the nearest competitor, the U.S., Reuters reported citing U.N. data. Patent filings related to Generative AI saw more than 50,000 applications submitted in the pastContinue Reading
blackdovfx/iStock via Getty Images China will develop over 50 new national and industrial benchmarks for AI by 2026, Reuters reported, citing the Chinese industry ministry. The objective is part of the guidelines the ministry issued on standardizing systems for the AI arena, the report added. Generative AI services have becomeContinue Reading
hapabapa/iStock Editorial via Getty Images Microsoft (NASDAQ:MSFT) is consolidating its retail stores in China, the company noted in response to media reports that it is closing its network of authorized physical retailers in the country, Reuters reported. The U.S. company does not directly operate physical retail stores in China andContinue Reading
Cesare Ferrari Apple (NASDAQ:AAPL) lost smartphone market share in China in May despite “deep” discounting, investment firm UBS said, citing data from Counterpoint Research. Shares rose 1.2% in early trading on Monday. Cupertino, Calif.-based Apple ended the month with 11% of the smartphone market, even as iPhone units rose 0.9%Continue Reading
helloabc/iStock Editorial via Getty Images Hollysys Automation (NASDAQ:HOLI) soared 14% in premarket trading after buyer Ascendent Capital Partners disclosed that it received all Chinese approvals for the $1.66 billion deal. Ascendent Capital Partners is working to complete the deal “expeditiously,” the buyer disclosed in a 13D/A filing on Monday. TheContinue Reading
Kevin Frayer Apple’s (NASDAQ:AAPL) iPhone shipments in China soared 40% in May amid retail partners cutting prices of the device by offering attractive discounts ahead of the country’s June shopping festival, Bloomberg News reported. The China Academy of Information and Communications Technology disclosed figures, which showed that smartphone shipments roseContinue Reading
Biogen (NASDAQ:BIIB) and its Japanese partner Eisai’s (OTCPK:ESALF) (OTCPK:ESAIY) breakthrough Alzheimer’s therapy, Leqembi (lecanemab), is now available in China, the companies announced late Thursday. Lecanemab is a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody and said to be the only approved treatment shown to reduce the rate of disease progressionContinue Reading
RomanBabakin/iStock Editorial via Getty Images A Huawei Technologies’ developed operating system called OpenHarmony is being promoted in China as a ‘national operating system’ to limit reliance on Microsoft’s (MSFT) Windows and Android, Reuters reported. A collection, consisting of a drone, bipedal robot, supermarket checkout and other devices, at the HarmonyContinue Reading
